AXIM BIOTECHNOLOGIES, INC. financial data

Symbol
AXIM on OTC
Location
San Diego, CA
Fiscal year end
31 December
Latest financial report
10-Q - Q2 2024 - 19 Aug 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.4% % -46%
Debt-to-equity -152% % 9.5%
Return On Assets -105% % 53%
Operating Margin -2497% % 83%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 301,958,824 shares 27%
Common Stock, Shares, Outstanding 294,458,824 shares 29%
Common Stock, Value, Issued $29,446 USD 29%

Income Statement

Label TTM Value / Value Unit Change %
Revenues $92,650 USD 254%
Research and Development Expense $90,644 USD -30%
Costs and Expenses $1,411 USD
Operating Income (Loss) $2,313,480 USD 40%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest $4,135,873 USD 56%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $4,135,873 USD 56%
Earnings Per Share, Basic 0 USD/shares 67%
Earnings Per Share, Diluted 0 USD/shares 67%

Balance Sheet

Label TTM Value / Value Unit Change %
Assets, Current $20,243 USD -79%
Property, Plant and Equipment, Net $117,993 USD 52%
Operating Lease, Right-of-Use Asset $182,686 USD -32%
Assets $3,727,695 USD -12%
Liabilities, Current $6,572,371 USD -21%
Long-term Debt and Lease Obligation $93,847 USD
Liabilities $13,262,485 USD -5.2%
Retained Earnings (Accumulated Deficit) $74,746,972 USD -5.9%
Stockholders' Equity Attributable to Parent $9,534,790 USD 2.2%
Liabilities and Equity $3,727,695 USD -12%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $252,506 USD -78%
Net Cash Provided by (Used in) Financing Activities $195,599 USD 32%
Net Cash Provided by (Used in) Investing Activities $2,839 USD
Common Stock, Shares Authorized 1,000,000,000 shares 233%
Common Stock, Shares, Issued 294,458,824 shares 29%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $6,044 USD -94%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD
Depreciation $35,200 USD 8.2%
Payments to Acquire Property, Plant, and Equipment $2,839 USD
Lessee, Operating Lease, Liability, to be Paid $196,380 USD
Property, Plant and Equipment, Gross $259,631 USD 41%
Lessee, Operating Lease, Liability, to be Paid, Year Two $102,684 USD
Lessee, Operating Lease, Liability, to be Paid, Year One $50,010 USD
Lessee, Operating Lease, Liability, to be Paid, Year Three $43,686 USD
Preferred Stock, Shares Authorized 5,000,000 shares 0%
Additional Paid in Capital $65,183,686 USD 7.1%
Amortization of Intangible Assets $98,612 USD 0%
Share-based Payment Arrangement, Expense $93,905 USD -89%
Interest Expense $178,244 USD -76%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%